The US Food and Drug Administration (FDA) held a 2-day public hearing this week to solicit input about the marketing and use of medications and medical devices for off-label use. It is fairly common ...

The Food and Drug Administration is in the midst of a two-day hearing to discuss whether drug companies and devicemakers should be allowed to promote unapproved uses of medical products to physicians, ...

Developers of a lab-grown blood vessel designed to save life and limb in emergency scenarios appear to be promoting its use in surgeries far beyond what the Food and Drug Administration has approved ...

The FDA issued draft guidelines that would allow drug and device makers to provide information on off-label uses, but only if the request for information is unsolicited, or one not initiated by the ...